Susquehanna International Group
VIR icon

Susquehanna International Group’s Vir Biotechnology VIR Stock Holding History

Susquehanna International Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Sell
195,561
-194,497
-50% -$1.55M ﹤0.01% 6477
2025
Q4 		$2.35M Buy
390,058
+112,355
+40% +$669K ﹤0.01% 5307
2025
Q3 		$1.59M Buy
277,703
+71,302
+35% +$365K ﹤0.01% 6280
2025
Q2 		$1.04M Sell
206,401
-3,260
-2% -$17.5K ﹤0.01% 7328
2025
Q1 		$1.36M Buy
209,661
+31,523
+18% +$280K ﹤0.01% 6471
2024
Q4 		$1.31M Buy
178,138
+89,530
+101% +$706K ﹤0.01% 6308
2024
Q3 		$664K Buy
88,608
+22,716
+34% +$197K ﹤0.01% 7797
2024
Q2 		$586K Sell
65,892
-24,977
-27% -$240K ﹤0.01% 7878
2024
Q1 		$921K Buy
90,869
+18,341
+25% +$187K ﹤0.01% 7103
2023
Q4 		$730K Sell
72,528
-61,913
-46% -$566K ﹤0.01% 7762
2023
Q3 		$1.26M Buy
134,441
+82,678
+160% +$1.18M ﹤0.01% 6101
2023
Q2 		$1.27M Sell
51,763
-110,892
-68% -$2.78M ﹤0.01% 6141
2023
Q1 		$3.78M Buy
162,655
+130,249
+402% +$3.33M ﹤0.01% 3879
2022
Q4 		$820K Sell
32,406
-131,978
-80% -$3.23M ﹤0.01% 6617
2022
Q3 		$3.17M Buy
164,384
+109,865
+202% +$2.79M ﹤0.01% 3968
2022
Q2 		$1.39M Sell
54,519
-287,659
-84% -$6.72M ﹤0.01% 5737
2022
Q1 		$8.8M Buy
342,178
+151,194
+79% +$4.48M ﹤0.01% 2727
2021
Q4 		$8M Buy
190,984
+33,129
+21% +$1.3M ﹤0.01% 3023
2021
Q3 		$6.87M Buy
157,855
+59,170
+60% +$2.56M ﹤0.01% 3438
2021
Q2 		$4.67M Buy
98,685
+84,516
+596% +$3.84M ﹤0.01% 4158
2021
Q1 		$726K Sell
14,169
-58,391
-80% -$3.15M ﹤0.01% 8566
2020
Q4 		$1.94M Buy
72,560
+19,878
+38% +$646K ﹤0.01% 5167
2020
Q3 		$1.81M Sell
52,682
-12,440
-19% -$536K ﹤0.01% 4817
2020
Q2 		$2.67M Buy
65,122
+53,605
+465% +$1.8M ﹤0.01% 3993
2020
Q1 		$395K Buy
+11,517
New +$310K ﹤0.01% 7436

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Susquehanna International Group's VIR Position: Q1 2026 in Review

Susquehanna International Group reduced its Vir Biotechnology (VIR) stake by 50% in Q1 2026, selling an estimated $1.55M and leaving 195,561 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #6477.

Susquehanna International Group first reported a position in VIR in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.8M in Q1 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Susquehanna International Group held 195,561 shares of Vir Biotechnology worth $1.75M as of Q1 2026.
  • Susquehanna International Group sold 194,497 Vir Biotechnology shares in Q1 2026, an estimated $1.55M.
  • Vir Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6477 holding.
  • Susquehanna International Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 25 quarters since.
  • Susquehanna International Group's Vir Biotechnology position peaked at $8.8M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.